This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
(Updates from 11:12 a.m. ET with closing information.)
NEW YORK (
TheStreet) -- Here's what Jim Cramer had to say on
CNBC's "Squawk On The Street" Monday:
Cramer said he likes
Biogen Idec (BIIB - Get Report). Deutsche Bank says it's not too late to buy, Cramer said. "The [prescriptions] are really unbelievable for its MS drug and I understand that. It makes sense." BIIB closed down 3.1% to $215.73.
Cliffs Natural Resources (CLF - Get Report) should be avoided, Cramer said. "People want a cyclical stock so bad. May I suggest
Vale(VALE)?" CLF was up 5.5% at $21.01.
On Morgan Stanley raising its rating on
UnitedHealth (UNH - Get Report), Cramer said the stock has been the "big laggard" in the sector.
Aetna(AET) has moved ahead,
Humana's(Hum) moved ahead," Cramer said, adding Morgan's action is "a good call." UNH was 2.2% higher at $60.20.
Cramer said the rap against
Bank of America (BAC - Get Report) has been mortgage-related private lawsuits. Now that the bank is starting to get some settlements on these, "You want to buy Bank of America," he advised. BAC rose 5.2% to $12.88 Monday.
Cramer summed up
Groupon(GRPN - Get Report) in one word: "Nevermind." GRPN dropped 6.5% to $5.46.
Morgan Stanley changed its rating on
ADT(ADT - Get Report) from sell to hold. "Morgan Stanley has targeted this stock, it's the main reason it went down," Cramer said. "They reiterated that they hate it. It has been a complete bow-wow." ADT ended the day 2% higher at $44.36.
To sign up for Jim Cramer's free Booyah! newsletter, with all of his latest articles and videos, please click here.-- Written by Anthony Buccino in New York.Follow @AnthonyBuccino